中南大学李捷

当前位置: 中文主页 >> 论文成果

Dupilumab therapy in children aged 2-12？years with uncontrolled moderate-to-severe atopic dermatitis: A Chinese real-world study.

发布时间：2025-11-18

点击次数：

发表刊物：J Eur Acad Dermatol Venereol

是否译文：否

上一条： Effectiveness and safety of dupilumab in moderate-to-severe atopic dermatitis patients with chronic renal insufficiency: a real-world retrospective study in China.

下一条： Plasma adenosine is linked to disease activity and response to treatment in patients with chronic spontaneous urticaria